Final Program

TUESDAY • MAY 17 285
P1192 Extrapulmonary Tuberculosis: A Retrospective Review of 331
Cases at Kocaeli Tuberculosis Dispansary/A. Sengul, N. Ogan,
Y. Aydemir, Kocaeli, Turkey, p.A5518
P1193 Knowledge of People Living with HIV (PLWH) to Tuberculosis -
HIV Coinfection/R. Nur Febri, R. Wisaksana, B.W. Lestari,
Cirebon, Indonesia, p.A5519
P1194
P1195
P1196
Facilitator:
P1197
P1198
P1199
P1200
P1201
P1202
P1203
Facilitator:
P1204
HIV Infection Among Patients with Tuberculosis Enrolled in
Directly Observed Treatment, Short - Course (DOTS) Center in
Davao City: A Cross - Sectional Study/M.J.A. Dalayon, C. Uy, J.
Itable, A. Lopez, Davao City, Philippines, p.A5520
Tuberculosis Associated with Human Immunodeficiency Virus
Infection in Mures County, Romania (10 Years, 2004-2013)/G.
Jimborean, R. Nemes, P. Postolache, O. Popa, E.S. Ianosi, Targu
Mures, Romania, p.A5521
Assessment of the Role of Bronchoalveolar Lavage Fluid
(BALF) and Serum Vitamin D Levels in AIDS Disease
Progression and Opportunistic Infections Amongst HIV and
Tuberculosis Co-Infected Individuals/S. Sinha, D. Mandal, P.
Kasana, New Delhi, India, p.A5522
P.K. Moonan, DrPH, MPH, Atlanta, GA
Clinical Course of Patients who Developed Tuberculosis After
Receiving Tumor Necrosis Factor-a Inhibitors/M.-A. Park, E.-J.
Park, S.-H. Kim, I.K. Hwang, J.J. Hwang, H.M. Kang, J.H. Yoo, M.J.
Park, Seoul, Korea, Republic of, p.A5523
Immunosuppressant Drugs and Tuberculosis: Patient’s
Features in a University Hospital/B.M. Pinto, L. Gama, C. Miranda,
R. Vargas, A.P. Santos, W. Costa, D. Capone, H.R. Siqueira, C.H.D.
Costa, J. Leung, R. Rufino, Rio de Janeiro, Brazil, p.A5524
Analysis of Risk Factors for Early and Late Default Among
Active Tuberculosis Patients/J. Kim, J.H. Ahn, A.Y. Shin, H.S.
Kang, Y.H. Kim, H.S. Moon, J.H. Ha, H.J. Kim, Korea, Republic of,
p.A5525
Detainment of Patients with Tuberculosis Under Section 38 of
the Health Act, 1947 in Ireland/L. Khorsheed, M. Murray, T.
O’Connor, Cork, Ireland, p.A5526
Treatment Outcomes of Tuberculosis Patients: Cohort 2014 in
a Private Sector in Cali, Colombia/L. Fernandez, J.F. Garcia, K.
Monroy, C.A. Munoz, Cali, Colombia, p.A5527
Sustainability and TB Outcomes of a Community Based Health
Service Project: 3 Year Evaluation of a Solok District,
Indonesia/R. Machmud, Z. Zulhendrizon, F. Purba, S. Supriyadi,
M. Masrul, D. Delyuzar, Padang, Indonesia, p.A5528
Validation of Tuberculosis Outcome and Social Support
Questionnaire (TOSQ) Among Nigerian Workers/G.C. Isiguzo,
C.N. Ugwu, K. Ukwaja, M.O. Iroezindu, G.A. Amusa, B.I. Awokola,
C.J. Lane, B.C. Ezeokpo, Abakaliki, Nigeria, p.A5529
T.M. O’Connor, MD, Cork, Ireland
Cough- and Sputum-Related Quality of Life in Pulmonary
Tuberculosis/T. Suzuki, Y. Tanaka, H. Watanabe, Y. Endo, Y.
Shimoda, I. Hayashi, S. Sakurai, M. Saigusa, T. Akamatsu, A.
Yamamoto, Y. Shishido, T. Akita, S. Morita, K. Asada, T. Shirai,
Shizuoka, Japan, p.A5530
P1205
P1206
P1207
P1208
P1209
P1210
P1211
P1212
C59
Evaluation of Clinic and Radiologic Findings and Side Effect
Profiles in Pulmonary Tuberculosis Patients, A Single Center
Experience/A. Sengul, Kocaeli, Turkey, p.A5531
Effect of Emergency Liver Transplantation on the Survival of
Patients with Antituberculous Therapy-Induced Acute Liver
Failure/J.-Y. Huh, K.-W. Jo, T.S. Shim, Seoul, Korea, Republic of,
p.A5532
An Update on the Trends and Treatment in Multidrug-Resistant
Tuberculosis/I.R. Reynolds, E.D. Chan, Denver, CO, p.A5533
Rifampicin-Sparing Treatment in Pulmonary Tuberculosis
Patients with Rifampicin-Mono-Resistance or Rifampicin
Adverse Event/S. Park, K.W. Jo, S.D. Lee, W.S. Kim, T.S. Shim,
Seoul, Korea, Republic of, p.A5534
Drug Susceptibility of Mycobacteria in Moscow Region/V.I.
Litvinov, M.V. Makarova, M. Krasnova, R. Galkina, L. Krilova, E.
Khachaturyants, I. Peretokina, Moscow, Russian Federation,
p.A5535
The Role of Histone Deacetylases in the Innate Immune
Response to Mycobacterium Tuberculosis Infection/M. Campo,
C. Seshadri, C.M. Stein, G.J. Peterson, R.D. Wells, H.
Mayanja-Kizza, W.H. Boom, T.R. Hawn, Seattle, WA, p.A7886
Evaluation of Optimal Regimens for Treatment of Rifampicin
Resistant-Tuberculosis: Multicenter, Randomized Controlled
Study in China/S. Tang, L. Yao, X. Hao, Y. Liu, Beijing, China,
p.A7887
iAdhere Study: Cost-Effectiveness of Self-Administered
Isoniazid/Rifapentine for Treatment of Latent Tuberculosis
Infection in the United States/D.P. Holland, D. Sheehan, A.
Wright, N.A. Scott, R.W. Belknap, A.S. Borisov, Atlanta, GA,
p.A7888
THEMATIC POSTER SESSION
TOPICS ON SELF-MANAGEMENT AND
SUPPORTIVE CARE ACROSS THE SPECTRUM OF
CHRONIC RESPIRATORY CONDITIONS
9:00 a.m. - 4:15 p.m. MOSCONE CENTER
Viewing: Posters will be on display for entire session.
Area F, Hall D (North Building, Lower Level)
Discussion: 11:00-11:45: authors will be present for individual discussion
11:45-12:45: authors will be present for discussion with assigned facilitators
Facilitator:
P629
P630
P631
L. Matura, PhD, RN, Philadelphia, PA
An Exploration of the Transition Readiness Needs of Urban
African American Youth with Asthma/W.M. Gibson-Scipio, K.
Kolmodin MacDonell, C. Pearson, Detroit, MI, p.A5537
General Health Perception in People with Exacerbated
COPD/S.K. Park, Korea, Republic of, p.A5538
Self Care Behavior in People with Exacerbated COPD/
S.K. Park, Korea, Republic of, p.A5539
TUESDAY MORNING
ATS 2016 • San Francisco